Clinical Trials Directory

Trials / Unknown

UnknownNCT06242717

Postpartum Screening for Anxiety and Comorbid Conditions

Postpartum Screening for Anxiety and Comorbid Conditions: A Prospective British Columbia Cohort Study

Status
Unknown
Phase
Study type
Observational
Enrollment
550 (estimated)
Sponsor
University of British Columbia · Academic / Other
Sex
Female
Age
19 Years
Healthy volunteers
Accepted

Summary

The goal of this project is to facilitate the design of individualized postpartum anxiety (PPA) screening strategies in British Columbia (BC), Canada. A cohort of postpartum people (n=550) will be invited to complete the following seven questionnaires at 4-8 weeks after delivery: 1. State-Trait Anxiety Inventory 2. Edinburgh Postnatal Depression Scale 3. Multidimensional Scale of Perceived Social Support 4. PROMIS (Patient-Reported Outcomes Measurement Information System) Emotional Distress-Anger, Short Form 5-a 5. Short Form Brief Pain Inventory 6. WHOQOL-BREF for assessing quality of life 7. PROMIS Sleep Disturbance Short Form 8-b and PROMIS Sleep-Related Impairment Short Form 8-a The investigators will evaluate the feasibility of screening for postpartum anxiety and comorbid conditions through a web-based platform in a diverse BC population. They will assess the usability of the platform and questionnaires through 12-15 follow-up interviews with study participants and responses to the System Usability Scale. Their analysis will also identify patient characteristics and comorbidities (e.g., anger, pain, sleep disturbance) associated with a positive screen for postpartum anxiety.

Conditions

Timeline

Start date
2023-11-09
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2024-02-05
Last updated
2024-02-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06242717. Inclusion in this directory is not an endorsement.